Member Info for CHELSEA7

Bermuda,

Well I asked the question, you gave an answer. I agree.

I just get the impression, as you have over different issues, that that will not suffice, but it would me. Thamks.

Thanks for reply Ivy, I guess you have both notied the last few weeks I have been only too happy to read the posts rather than join in, and hve merely commented on some very good posts, regardless of whether itis what I want to hear.

The only point I have raised the last couple of days is what we would suggest Scancell can say in regard to the trials whilst there is no certainty when trials can begin, which is made even more difficult IMHO by the threat of a 2nd wave of this virus in a couple of months. Just judging by a few pubs already closing down with an increase of coronavirus casualties, just as one example, it isn"t looking too good.

Bermudashorts,

No confusion from me Bermuda, i too would love to her as many updates as possible, but for example what would Scancell say with regards to SCIB1 and MOD1 trials to show us we are in a strong position to weather the storm???

Without raising funds, and short of a deal with Avidamab to negate any need for a raise, what is there to add to we are not in trials??

Ray, so true. The vast majority of communication complaints involves price sensitive information, which even asking the company will never be answered. We actually did get a couple of RNSs late end June, publication highlights for both MOD1 and Avidamab, it is just the news released as updates is not the type of news traders choose IMHO

5.30/5.60

Buys 168k

Sells 260k

Well it is just good to hear different views, the AIM market is so driven by news, and the opinions between traders and investors are often very different.

The RNS re COVIDITY was an ideal RNS for traders first, but what kind of update can the company release unles they have a fundraise to announce?? And is it not the same for our SCIB1 and MOD1 trial, what kind of update can we expect unless a definitive timeline can be given??

Ivy, by your own definition, you are a trader of AIM stocks, and also you have been stating the case for more updates more vocifically than most, but again by your own admission you have been trading this share very well the last few months, if as you say we are forced to second guess on key issues, some I agree with, on what basis with lack of news do you manage to trade this share so well.???

I ask because, one reason being, I too have made 4 good trades out of five since February, and have done so on the information given and like most shares what we can reasonably expect.

Hi Bunsie, a timely post if ever there was. Yesterday marked the first anniversary of my brothers death, he had kept it from me the last few years that he was seeing my oncologist and surgeon and finally he passed away from sarcomas that had left his lung. I would of gladly swapped all the $$$$ to have saved his life.

I don"t think though that seeing our potential is the issue, we just must get back into trials, collating data and convincing investors to fund us through the trials we are ready to begin. What I would say to some is what is it they want updated, until such time as we can say with certainty that trials can begin????

Michaelhighbar, no it wasn"t your posts that sent me to sleep, lol, far from it, lets just say I found yesterdy emotionally draining. Looking forward to reading more from you, welome aboard.

GN

Buys 560k

Sells 382k

+2.80%....................20 trades....................GN

5.3/5.7

+2.80%

Maybe time for bid too.

Taking 180k shares at 5.41

For 40k, last few trades, all buys....................

16:13:26 5.55 40,000 2,220 O
16:09:40 5.494 10,000 549.40 O
15:39:50 5.494 8,875 487.59 O
15:16:05 5.494 7,280 399.96 O
13:23:36 5.494 3,535 194.21 O

Well done buddy on your 86k top up. Thinking the same, don"t think it will take much news to rise 40% from here, and apart from COVIDITY it may well be our first commercial deal on Avidamab that sets the share alive again. GL

Buys 360k

Sells 384k

+1.87%

Afternoon, was replying to your posts yesterday morning around 2 and must have just fallen asleep, such is the life of a stressed out Chelsea fan ATM, lol.

Appreciate your posts yesterday and today, they make for good debate, not always clear to come into any conclusions on certain issues but with the SP trading now in the low 5s, and so much uncertainty around (the market loves that!!) worthy of discussion for sure. Thanks

Interesting part guys................

Gaps must be filled
There is an assumption amongst some traders that gaps must be filled, meaning that the price is expected to return to the gap area at a future date.

Breakaway and runaway gaps are believed to have a lower probability of being filled. This is due to the assumption that the market event which caused this type of gap to occur carries a strong directional momentum. Trading for a gap fill would therefore equate to trading against this momentum and trading against the newly formed trend.

Traders looking to trade a ‘gap fill’ might prefer to do so in the event of an exhaustion gap. An exhaustion gap suggests the directional move to be capitulating and possibly reversing course. This assumes a higher probability to trading for a ‘gap fill’

LL, good post. I am not so sure proven is the word, as MOD1 and even more SCIB1 are proven enough to go for trial , nd the problem with receiving any updates here is until we know eactly where and when we can go to trial, what can they say more in an update??

With regard to Biontech/TCR we can only expect an update if the collaboration is extended or a commercial deal comes from it, which is exactly the same for Avidamab and the three collaborations we have which the first of is coming towards it"s 12 month period. However, IF we can get a Commercial Deal on the first it is my opinion that could expedite deals on the other two before the 12 month period perhaps.

Given this and the big question mark over when trials can resume, that leaves COVIDITY. I was pleased to hear we now feature in the who list, but as Bermudashorts says it means no more than that at this stage. So the importance of a funding deal for COVIDITY is palpable, it could set so many wheels in motion needless to say add value and interest in any funding that may come late for the SCIB1 trial.

Once again I do believe we will get a raise similar to the Vulpes one last year, remeber VULPES cannot exceed a 29.99% holding, and also when VULPES bought their first tranche the hare did rise to 9.4p briefly from the mid 3s at one stage. It is a hard one, an update is further price sensitive information that we are not aware of, I think from that it is clear what we need to happen to trigeer any RNS. Really hoping we get this funding for COVIDITY, it could well be the turning point for us, and also help to validate SCIB1 further.

WTP, and that my friend is it in a nutshell.!!

Time Trade Price Volume Value
09:09:47 5.235 50,000 2,618 O
09:04:16 5.30 100,000 5,300 O
09:03:03 5.40 27,703 1,496 O
08:10:17 5.315 8,087 429.82 O
08:05:02 5.35 12,278 656.87 O

WTP, whwn I sold 24k at 6.40 for a .70 loss, it was just my opinion at the time we were heading for 5p. Unfortunately it seems we are.................keep punching

5.20/5.50

But 50k at 5.32.............80k+ 5.23

Busy movements on the bid this morning, should be plenty of trades today